HBM HOLDINGS-B (02142.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec18

Harbor BioMed Enters into Global Strategic Collaboration with Bristol Myers Squibb for Next-Generation Multi-Specific Antibodies

06:26

Dec8

Harbour BioMed-B repurchased 100,000 shares on December 5

01:53

Nov24

Hibrotech Further Expands Collaboration with AstraZeneca

00:04

Nov19

Harbor BioMed's Subsidiary NonaBio Signs Non-Exclusive Agreement with Pfizer

12:09

Nov17

Harbor BioMed-B repurchased 100,000 shares for HKD1.375 million

10:42

Nov13

Harbour BioMed-B repurchased 200,000 shares for HKD 2.7011 million

11:05

Schedules & Filings

Schedules

Filings

Aug27

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 397.66 M, Net Income 281.49 M, EPS 0.3595

Mar31

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 55.91 M, Net Income 5.257 M, EPS 0.0065

Aug28

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 92.54 M, Net Income 5.56 M, EPS 0.0074

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More